Literature DB >> 31495002

Identifying determinants for the application of physical or chemical restraint in the management of psychomotor agitation on the critical care unit.

Angela Teece1, John Baker1, Helen Smith1.   

Abstract

AIMS AND
OBJECTIVES: To identify key determinants, which lead to the decision to apply physical or chemical restraint on the critical care unit.
BACKGROUND: Psychomotor agitation and hyperactive delirium are frequently cited as clinical rationale for initiating chemical and physical restraint in critical care. Current restraint guidance is over a decade old, and wide variations in nursing and prescribing practice are evident. It is unclear whether restraint use is grounded in evidence-based practice or custom and culture. STUDY
DESIGN: Integrative review.
METHOD: Seven health sciences databases were searched to identify published and grey literature (1995-2019), with additional hand-searching. The systematic deselection process followed PRISMA guidance. Studies were included if they identified physical or chemical restraint as a method of agitation management in adult critical care units. Quality appraisal was undertaken using Mixed Methods Appraisal Tool. Data were extracted, and thematic analysis undertaken.
RESULTS: A total of 23 studies were included. Four main themes were identified: the lack of standardised practice, patient characteristics associated with restraint use, the struggle in practice and the decision to apply restraint.
CONCLUSIONS: There are wide variations in restraint use despite the presence of international guidance. Nurses are the primary decision-makers in applying restraint and report that caring for delirious patients is physically and psychologically challenging. The decision to restrain can be influenced by the working environment, patient behaviours and clinical acuity. Enhanced clinical support and guidance for nurses caring for delirious patients is indicated. RELEVANCE TO CLINICAL PRACTICE: Delirium and agitation pose a potential threat to patient safety and the maintenance of life-preserving therapies. Restraint is viewed as one method of preserving patient safety. However, use appears to be influenced by previous adverse experiences and subjective patient descriptors, rather than robust evidence-based knowledge. The need for a precise language to describe restraint and quantify when it becomes necessary is indicated.
© 2019 John Wiley & Sons Ltd.

Entities:  

Keywords:  agitation; critical care; decision-making; delirium; intensive care; nursing; restraint

Mesh:

Substances:

Year:  2019        PMID: 31495002     DOI: 10.1111/jocn.15052

Source DB:  PubMed          Journal:  J Clin Nurs        ISSN: 0962-1067            Impact factor:   3.036


  5 in total

1.  Attitudes of Nursing Staff in Hospitals towards Restraint Use: A Cross-Sectional Study.

Authors:  Silvia Thomann; Gesche Gleichner; Sabine Hahn; Sandra Zwakhalen
Journal:  Int J Environ Res Public Health       Date:  2022-06-10       Impact factor: 4.614

Review 2.  Responses Presented by Adult Patients with COVID-19, Based on the Formulated Nursing Diagnoses: A Scoping Review.

Authors:  Vanessa Cortinhal; António Pereira; Sofia Correia; Sérgio Deodato
Journal:  Int J Environ Res Public Health       Date:  2022-05-23       Impact factor: 4.614

3.  What does coercion in intensive care mean for patients and their relatives? A thematic qualitative study.

Authors:  Susanne Jöbges; Corine Mouton Dorey; Rouven Porz; Bara Ricou; Nicola Biller-Andorno
Journal:  BMC Med Ethics       Date:  2022-02-05       Impact factor: 2.652

4.  Restraining patients in acute care hospitals-A qualitative study on the experiences of healthcare staff.

Authors:  Sandra Siegrist-Dreier; Isabelle Barbezat; Silvia Thomann; Dirk Richter; Sabine Hahn; Kai-Uwe Schmitt
Journal:  Nurs Open       Date:  2022-01-28

5.  Factors associated with the decision to prescribe and administer antipsychotics for older people with delirium: a qualitative descriptive study.

Authors:  Emily J Tomlinson; Helen Rawson; Elizabeth Manias; Nicole Nikki M Phillips; Peteris Darzins; Alison M Hutchinson
Journal:  BMJ Open       Date:  2021-07-07       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.